Provided are fully human antibodies that bind to toxin A and toxin B of Clostridium difficile. The antibodies are useful for neutralizing the toxins from C. difficile, thus providing a means of treating the disease and symptoms associated with C. difficile infection, including the treatment of diarrhea, or pseudomembranous colitis caused by C. difficile. The antibodies may also prevent the severity and duration of the primary disease, or may prevent the number, duration and the severity of recurrences, or relapses of the disease attributed to the presence of C. difficile.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.